AzTrials
AzTrials

Crowding of Anterior Mandibular TeethNCT04815200

Efficiency of Using Copper-Nickel-Titanium Versus Nickel-Titanium Arch Wires on Anterior Segment Crowding Alleviation in Group of Adults With Moderate Crowding

A study testing Copper Nickel titanium arch wire in people with Crowding of Anterior Mandibular Teeth, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluate the efficiency of using copper nickel titanium (CuNiTi) arch wire on the initial stage of leveling and alignment regarding their rate of alignment in comparison to Conventional Nickel Titanium arch wire (NiTi) by Measuring the amount and rate of alignment achieved every 2 weeks for a period of 2 months. . Read more about this study

Who is it for?
Ages 18 to 33 yearsHealthy volunteers can take part
Conditions the study is for
Crowding of Anterior Mandibular Teeth
What is being tested?
Copper Nickel titanium arch wire
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
18 Mar 2021to 18 Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 33 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adult patients aged (18~33).
  • Moderate crowding (4-8)10.
  • No extractions required.

Who cannot join

  • Previous orthodontic treatment.
  • Missing teeth other than the wisdoms.
  • Patient with dental anomalies.
  • Patient having a deep bite, open bite or cross bite.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • faculty of dentistry, Cairo University

    Cairo, Manial, 12613

    - Faculty Official Mail, (+202) 23634965, dentmail@dentistry.cu.edu.eg

    Information mail, (+202) 23642938, info@dentistry.cu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Efficiency of Using Copper-Nickel-Titanium Versus Nickel-Titanium Arch Wires on Anterior Segment Crowding Alleviation in Group of Adults With Moderate Crowding: A Randomized Controlled Clinical Trial

Evaluate the efficiency of using copper nickel titanium (CuNiTi) arch wire on the initial stage of leveling and alignment regarding their rate of alignment in comparison to Conventional Nickel Titanium arch wire (NiTi) by Measuring the amount and rate of alignment achieved every 2 weeks for a period of 2 months.

.

Read the detailed description

Leveling and alignment is the first stage in fixed orthodontic treatment, performed for every patient. Copper nickel titanium (CuNiTi) was modified from conventional nickel titanium (NiTi) to stabilize the super elasticity properties of the initial nickel titanium (NiTi) arch wire against cyclic deformation. The addition of copper to traditional nickel titanium enhances thermal reactive properties and consistency of forces.so the aim of the study is to Evaluate the efficiency of using copper nickel titanium (CuNiTi) arch wire on the initial stage of leveling and alignment regarding their rate of alignment.

Being tested
Copper Nickel titanium arch wire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Copper Nickel titanium arch wireDevice

    Also called CuNiTi

    Patient will receive 0.014 round Copper Nickel titanium CuNiTi archwire and will be ligated using a ligature wire.

Study groups in NCT04815200
Study groupRoleWhat they receive
Nickel titanium NiTi arch wire (Gold Standard, control group)OtherPatient will receive 0.014 round Nickel titanium NiTi archwire and will be ligated using a ligature wire with Follow up for 2 months.
Receives: Device: Copper Nickel titanium arch wire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of alignment.

    Measuring the amount and rate of alignment of teeth which achieved every 2 weeks for a period of 8 weeks using (mm) as numerical unit of measurement and method of measurement is '' Little's irregularity index''

    Measured: 8 weeks

Secondary outcomes (3)
  1. inter-canine arch perimeter width

    measure inter canine perimeter width every 2 weeks using Unit of measurement numerical (mm) though ortho analyzer 3shape software

    Measured: 8 weeks

  2. pain assessed by NRS

    measuring pain associated after placement of the wire through printed copy of numerical rating pain scale with a person rates their pain on a scale of 0 to 10,Zero means "no pain," while 10 means "the worst possible pain."

    Measured: first 24 hours

  3. inter-molar arch perimeter width.

    measure inter-molar arch perimeter width every 2 weeks using a numerical unit of measurement (mm) through ortho analyzer 3shape software

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2021
  2. Study start18 Mar 2021 (estimated)
  3. Primary completion18 Mar 2022 (estimated)
  4. Study completion18 Apr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Patient will receive 0.014 round Copper Nickel titanium CuNiTi archwire and will be ligated using a ligature wire
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04815200
Sponsor's protocol ID
25121
Status last verified
Mar 2021
First submitted
18 Mar 2021
Last updated
24 Mar 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Copper Nickel titanium arch wire in people with Crowding of Anterior Mandibular Teeth, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed El Gendy, BDS (01062266555, mohamed.bedir@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of alignment. (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in